Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Oct;95(2):501–511. doi: 10.1111/j.1476-5381.1988.tb11670.x

An attempt at selective protection from phenoxybenzamine of postjunctional alpha-adrenoceptor subtypes mediating contractions to noradrenaline in the rabbit isolated saphenous vein.

C J Daly 1, W R Dunn 1, J C McGrath 1, V G Wilson 1
PMCID: PMC1854164  PMID: 2906558

Abstract

1. An attempt has been made, with the irreversible alpha-adrenoceptor antagonist phenoxybenzamine, to find the conditions under which postjunctional alpha 1-adrenoceptors in the rabbit isolated saphenous vein can be inactivated, such that postjunctional alpha 2-adrenoceptors can be studied in isolation. 2. Following exposure to various concentrations of phenoxybenzamine, no evidence was found for a selective inactivation of the postjunctional population of alpha 1-adrenoceptors: the "rauwolscine-resistant' (alpha 1-) and the "rauwolscine-sensitive' (alpha 2-) responses to (--)-noradrenaline were similarly affected. 3. However, in "receptor protection' experiments following exposure to a combination of phenoxybenzamine and the selective alpha 2-adrenoceptor antagonist rauwolscine, the remaining response to (--)-noradrenaline appeared to be mediated by a single population of postjunctional alpha 2-adrenoceptors: the response was insensitive to prazosin and rauwolscine was more potent than corynanthine. 4. Partial isolation of the alpha 1-adrenoceptor population was attempted by pre-exposure of the preparation to a combination of phenoxybenzamine and a selective alpha 1-adrenoceptor antagonist, i.e. prazosin or YM-12617. Following receptor protection, the inhibition produced by "selective' concentrations of either of these alpha 1-adrenoceptor antagonists were not significantly different from that observed in control preparations (no phenoxybenzamine). However, the selective alpha 2-adrenoceptor antagonists rauwolscine and CH-38083 were still able to inhibit part of the remaining responses to NA. This is interpreted as indicating that, in addition to protecting the putative postjunctional alpha 1-adrenoceptors, these procedures fail to produce complete inactivation of postjunctional alpha 2-adrenoceptors. 5. It is concluded that, although phenoxybenzamine appeared to be non-selective for the two populations of postjunctional alpha-adrenoceptors in the rabbit isolated saphenous vein, inclusion of a "selective' concentration of a competitive antagonist during the inactivation period results in differing degrees of functional protection of each subtype. Pharmacological isolation was possible for alpha 2-adrenoceptors but not convincingly for alpha 1-adrenoceptors.

Full text

PDF
501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alabaster V. A., Keir R. F., Peters C. J. Comparison of activity of alpha-adrenoceptor agonists and antagonists in dog and rabbit saphenous vein. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jul;330(1):33–36. doi: 10.1007/BF00586706. [DOI] [PubMed] [Google Scholar]
  3. Ariëns E. J., Simonis A. M. Physiological and pharmacological aspects of adrenergic receptor classification. Biochem Pharmacol. 1983 May 15;32(10):1539–1545. doi: 10.1016/0006-2952(83)90324-6. [DOI] [PubMed] [Google Scholar]
  4. Borowski E., Starke K., Ehrl H., Endo T. A comparison of pre- and postsynaptic effects of alpha-adrenolytic drugs in the pulmonary artery of the rabbit. Neuroscience. 1977;2(2):285–296. doi: 10.1016/0306-4522(77)90095-1. [DOI] [PubMed] [Google Scholar]
  5. Cocks T. M., Jenkinson D. H., Koller K. Interactions between receptors that increase cytosolic calcium and cyclic AMP in guinea-pig liver cells. Br J Pharmacol. 1984 Sep;83(1):281–291. doi: 10.1111/j.1476-5381.1984.tb10144.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Constantine J. W., Lebel W., Archer R. Functional postsynaptic alpha 2- but not alpha 1-adrenoceptors in dog saphenous vein exposed to phenoxybenzamine. Eur J Pharmacol. 1982 Dec 3;85(3-4):325–329. doi: 10.1016/0014-2999(82)90219-9. [DOI] [PubMed] [Google Scholar]
  7. Daly C. J., McGrath J. C., Wilson V. G. An examination of the postjunctional alpha-adrenoceptor subtypes for (-)-noradrenaline in several isolated blood vessels from the rabbit. Br J Pharmacol. 1988 Oct;95(2):473–484. doi: 10.1111/j.1476-5381.1988.tb11668.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Daly C. J., McGrath J. C., Wilson V. G. Evidence that the population of postjunctional-adrenoceptors mediating contraction of smooth muscle in the rabbit isolated ear vein is predominantly alpha 2. Br J Pharmacol. 1988 Aug;94(4):1085–1090. doi: 10.1111/j.1476-5381.1988.tb11626.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Daly C. J., McGrath J. C., Wilson V. G. Pharmacological analysis of postjunctional alpha-adrenoceptors mediating contractions to (-)-noradrenaline in the rabbit isolated lateral saphenous vein can be explained by interacting responses to simultaneous activation of alpha 1- and alpha 2-adrenoceptors. Br J Pharmacol. 1988 Oct;95(2):485–500. doi: 10.1111/j.1476-5381.1988.tb11669.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Docherty J. R., Göthert M., Dieckhöfer C., Starke K. Effects of 4-chloro-2-(2-imidazolin-2-ylamino)-isoindoline Hydrochloride (BE 6143) at pre- and postsynaptic alpha-adrenoceptors in rabbit aorta and pulmonary artery. Arzneimittelforschung. 1982;32(12):1534–1540. [PubMed] [Google Scholar]
  11. Docherty J. R., Starke K. Postsynaptic alpha-adrenoceptor subtypes in rabbit blood vessels and rat anococcygeus muscle studied in vitro. J Cardiovasc Pharmacol. 1981 Jul-Aug;3(4):854–866. doi: 10.1097/00005344-198107000-00019. [DOI] [PubMed] [Google Scholar]
  12. Doxey J. C., Smith C. F., Walker J. M. Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors. Br J Pharmacol. 1977 May;60(1):91–96. doi: 10.1111/j.1476-5381.1977.tb16752.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dubocovich M. L., Langer S. Z. Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxybenzamine in blocking the pre- and post-synaptic adrenergic receptors. J Physiol. 1974 Mar;237(3):505–519. doi: 10.1113/jphysiol.1974.sp010495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Exton J. H. Mechanisms involved in alpha-adrenergic phenomena. Am J Physiol. 1985 Jun;248(6 Pt 1):E633–E647. doi: 10.1152/ajpendo.1985.248.6.E633. [DOI] [PubMed] [Google Scholar]
  15. Flavahan N. A., Rimele T. J., Cooke J. P., Vanhoutte P. M. Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein. J Pharmacol Exp Ther. 1984 Sep;230(3):699–705. [PubMed] [Google Scholar]
  16. Hieble J. P., Sulpizio A. C., Nichols A. J., DeMarinis R. M., Pfeiffer F. R., Lavanchy P. G., Ruffolo R. R., Jr Pharmacological differentiation of pre- and post-junctional alpha 2-adrenoceptors. J Hypertens Suppl. 1986 Dec;4(6):S189–S192. [PubMed] [Google Scholar]
  17. Honda K., Takenaka T., Miyata-Osawa A., Terai M., Shiono K. Studies on YM-12617: a selective and potent antagonist of postsynaptic alpha 1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jan;328(3):264–272. doi: 10.1007/BF00515552. [DOI] [PubMed] [Google Scholar]
  18. Hooker C. S., Calkins P. J., Fleisch J. H. On the measurement of vascular and respiratory smooth muscle responses in vitro. Blood Vessels. 1977;14(1):1–11. doi: 10.1159/000158110. [DOI] [PubMed] [Google Scholar]
  19. Hölting T., Starke K. Receptor protection experiments confirm the identity of presynaptic alpha 2-autoreceptors. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jul;333(3):262–270. doi: 10.1007/BF00512939. [DOI] [PubMed] [Google Scholar]
  20. Laher I., Khayal M. A., Bevan J. A. Norepinephrine-sensitive, phenoxybenzamine-resistant receptor sites associated with contraction in rabbit arterial but not venous smooth muscle: possible role in adrenergic neurotransmission. J Pharmacol Exp Ther. 1986 May;237(2):364–368. [PubMed] [Google Scholar]
  21. McGrath J. C. Evidence for more than one type of post-junctional alpha-adrenoceptor. Biochem Pharmacol. 1982 Feb 15;31(4):467–484. doi: 10.1016/0006-2952(82)90147-2. [DOI] [PubMed] [Google Scholar]
  22. Purdy R. E., Krueger C. G., Young S. Evidence for nonclassical alpha adrenoceptor blockade by prazosin in isolated rabbit blood vessels. Life Sci. 1980 Dec 8;27(23):2187–2195. doi: 10.1016/0024-3205(80)90383-5. [DOI] [PubMed] [Google Scholar]
  23. Ruffolo R. R., Jr, Rosing E. L., Waddell J. E. Receptor interactions of imidazolines. I. Affinity and efficacy for alpha adrenergic receptors in rat aorta. J Pharmacol Exp Ther. 1979 Jun;209(3):429–436. [PubMed] [Google Scholar]
  24. Ruffolo R. R., Jr, Zeid R. L. Relationship between alpha adrenoceptor occupancy and response for the alpha-1 adrenoceptor agonist, cirazoline, and the alpha-2 adrenoceptor agonist, B-HT 933, in canine saphenous vein. J Pharmacol Exp Ther. 1985 Dec;235(3):636–643. [PubMed] [Google Scholar]
  25. Schümann H. J., Lues I. Postjunctional alpha-adrenoceptors in the isolated saphenous vein of the rabbit. Characterization and influence of angiotensin. Naunyn Schmiedebergs Arch Pharmacol. 1983 Aug;323(4):328–334. doi: 10.1007/BF00512471. [DOI] [PubMed] [Google Scholar]
  26. Sugden D., Weller J. L., Klein D. C., Kirk K. L., Creveling C. R. Alpha-adrenergic potentiation of beta-adrenergic stimulation of rat pineal N-acetyltransferase. Studies using cirazoline and fluorine analogs of norepinephrine. Biochem Pharmacol. 1984 Dec 15;33(24):3947–3950. doi: 10.1016/0006-2952(84)90006-6. [DOI] [PubMed] [Google Scholar]
  27. Sulpizio A., Hieble J. P. Demonstration of alpha 2-adrenoceptor-mediated contraction in the isolated canine saphenous artery treated with Bay K 8644. Eur J Pharmacol. 1987 Mar 3;135(1):107–110. doi: 10.1016/0014-2999(87)90765-5. [DOI] [PubMed] [Google Scholar]
  28. Vanecek J., Sugden D., Weller J., Klein D. C. Atypical synergistic alpha 1- and beta-adrenergic regulation of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in rat pinealocytes. Endocrinology. 1985 Jun;116(6):2167–2173. doi: 10.1210/endo-116-6-2167. [DOI] [PubMed] [Google Scholar]
  29. Vizi E. S., Harsing L. G., Jr, Gaal J., Kapocsi J., Bernath S., Somogyi G. T. CH-38083, a selective, potent antagonist of alpha-2 adrenoceptors. J Pharmacol Exp Ther. 1986 Aug;238(2):701–706. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES